Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the pilot study is to test the efficacy and safety of riboflavin/Ultraviolet A
(UVA) cross-linked human donor corneas as carriers for the Boston Keratoprosthesis (Boston
KPro) in patients with higher risk for corneal melting (keratolysis).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Joseph B. Ciolino, MD Massachusetts Eye and Ear Infirmary